Mechanical stretch augments insulin-induced vascular smooth muscle cell proliferation by insulin-like growth factor-1 receptor

Experimental Cell Research

Volumn 317, Issue 17, 2011, Pages 2420-2428

  Liu, Gang ^a,b   Hitomi, Hirofumi ^a   Hosomi, Naohisa ^a   Lei, Bai ^a   Nakano, Daisuke ^a   Deguchi, Kazushi ^a   Mori, Hirohito ^a   Masaki, Tsutomu ^a   Ma, Hong ^b   Griendling, Kathy K ^c   Nishiyama, Akira ^a  

^a KAGAWA UNIVERSITY   (Japan)

^b CHINA MEDICAL UNIVERSITY   (China)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Insulin resistance; Insulin like growth factor 1 receptor; Mechanical stretch; Signal transduction; Vascular smooth muscle cell

Indexed keywords

DEOXYGLUCOSE; EPIDERMAL GROWTH FACTOR RECEPTOR KINASE; EPIDERMAL GROWTH FACTOR RECEPTOR KINASE INHIBITOR; INSULIN; INSULIN RECEPTOR; INSULIN RECEPTOR SUBSTRATE 1; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN KINASE B; PROTEIN TYROSINE KINASE; SMALL INTERFERING RNA; SOMATOMEDIN C RECEPTOR; THYMIDINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATHEROGENESIS; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVATION; HYPERINSULINEMIA; HYPERTENSION; MALE; MECHANICAL STRESS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; SMOOTH MUSCLE FIBER; STRETCHING; VASCULAR SMOOTH MUSCLE;

RATTUS;

EID: 80052621526     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2011.07.016     Document Type: Article

References (38)

1. Pravenec M., Kurtz T.W. Molecular genetics of experimental hypertension and the metabolic syndrome: from gene pathways to new therapies. Hypertension 2007, 49:941-952.
2. Sowers J.R., Standley P.R., Ram J.L., Jacober S., Simpson L., Rose K. Hyperinsulinemia, insulin resistance, and hyperglycemia: contributing factors in the pathogenesis of hypertension and atherosclerosis. Am. J. Hypertens. 1993, 6:260S-270S.
3. Howard G., O'Leary D.H., Zaccaro D., Haffner S., Rewers M., Hamman R., Selby J.V., Saad M.F., Savage P., Bergman R. Insulin sensitivity and atherosclerosis. The Insulin Resistance Atherosclerosis Study (IRAS) Investigators. Circulation 1996, 93:1809-1817.
4. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993, 362:801-809.
5. Suzuki L.A., Poot M., Gerrity R.G., Bornfeldt K.E. Diabetes accelerates smooth muscle accumulation in lesions of atherosclerosis: lack of direct growth-promoting effects of high glucose levels. Diabetes 2001, 50:851-860.
6. Taguchi A., White M.F. Insulin-like signaling, nutrient homeostasis, and life span. Annu. Rev. Physiol. 2008, 70:191-212.
7. Taniyama Y., Hitomi H., Shah A., Alexander R.W., Griendling K.K. Mechanisms of reactive oxygen species-dependent downregulation of insulin receptor substrate-1 by angiotensin II. Arterioscler. Thromb. Vasc. Biol. 2005, 25:1142-1147.
8. Hitomi H., Kiyomoto H., Nishiyama A., Hara T., Moriwaki K., Kaifu K., Ihara G., Fujita Y., Ugawa T., Kohno M. Aldosterone suppresses insulin signaling via the downregulation of insulin receptor substrate-1 in vascular smooth muscle cells. Hypertension 2007, 50:750-755.
9. Cheatham B., Vlahos C.J., Cheatham L., Wang L., Blenis J., Kahn C.R. Phosphatidylinositol 3-kinase activation is required for insulin stimulation of pp 70 S6 kinase. DNA synthesis, and glucose transporter translocation. Mol. Cell. Biol. 1994, 14:4902-4911.
10. Kanai F., Ito K., Todaka M., Hayashi H., Kamohara S., Ishii K., Okada T., Hazeki O., Ui M., Ebina Y. Insulin-stimulated GLUT4 translocation is relevant to the phosphorylation of IRS-1 and the activity of PI3-kinase. Biochem. Biophys. Res. Commun. 1993, 195:762-768.
11. D'Angelo G., Meininger G.A. Transduction mechanisms involved in the regulation of myogenic activity. Hypertension 1994, 23:1096-1105.
12. Johansson G.S., Arnqvist H.J. Insulin and IGF-I action on insulin receptors, IGF-I receptors, and hybrid insulin/IGF-I receptors in vascular smooth muscle cells. Am. J. Physiol. Endocrinol. Metab. 2006, 291:E1124-E1130.
13. Learoyd B.M., Taylor M.G. Alterations with age in the viscoelastic properties of human arterial walls. Circ. Res. 1966, 18:278-292.
14. Hitomi H., Fukui T., Moriwaki K., Matsubara K., Sun G.P., Rahman M., Nishiyama A., Kiyomoto H., Kimura S., Ohmori K., Abe Y., Kohno M. Synergistic effect of mechanical stretch and angiotensin II on superoxide production via NADPH oxidase in vascular smooth muscle cells. J. Hypertens. 2006, 24:1089-1095.
15. Cheng J., Du J. Mechanical stretch simulates proliferation of venous smooth muscle cells through activation of the insulin-like growth factor-1 receptor. Arterioscler. Thromb. Vasc. Biol. 2007, 27:1744-1751.
16. Nishiyama A., Yao L., Fan Y., Kyaw M., Kataoka N., Hashimoto K., Nagai Y., Nakamura E., Yoshizumi M., Shokoji T., Kimura S., Kiyomoto H., Tsujioka K., Kohno M., Tamaki T., Kajiya F., Abe Y. Involvement of aldosterone and mineralocorticoid receptors in rat mesangial cell proliferation and deformability. Hypertension 2005, 45:710-716.
17. Moriwaki K., Kiyomoto H., Hitomi H., Ihara G., Kaifu K., Matsubara K., Hara T., Kondo N., Ohmori K., Nishiyama A., Fukui T., Kohno M. Interferon-gamma enhances superoxide production in human mesangial cells via the JAK-STAT pathway. Kidney Int. 2006, 70:788-793.
18. Jia S., Liu Z., Zhang S., Liu P., Zhang L., Lee S.H., Zhang J., Signoretti S., Loda M., Roberts T.M., Zhao J.J. Essential roles of PI(3)K-p110beta in cell growth, metabolism and tumorigenesis. Nature 2008, 454:776-779.
19. Meng D., Shi X., Jiang B.H., Fang J. Insulin-like growth factor-I (IGF-I) induces epidermal growth factor receptor transactivation and cell proliferation through reactive oxygen species. Free Radic. Biol. Med. 2007, 42:1651-1660.
20. Ushio-Fukai M., Griendling K.K., Becker P.L., Hilenski L., Halleran S., Alexander R.W. Epidermal growth factor receptor transactivation by angiotensin II requires reactive oxygen species in vascular smooth muscle cells. Arterioscler. Thromb. Vasc. Biol. 2001, 21:489-495.
21. Chisalita S.I., Arnqvist H.J. Expression and function of receptors for insulin-like growth factor-I and insulin in human coronary artery smooth muscle cells. Diabetologia 2005, 48:2155-2161.
22. Federici M., Pandolfi A., De Filippis E.A., Pellegrini G., Menghini R., Lauro D., Cardellini M., Romano M., Sesti G., Lauro R., Consoli A. G972R IRS-1 variant impairs insulin regulation of endothelial nitric oxide synthase in cultured human endothelial cells. Circulation 2004, 109:399-405.
23. Scherrer U., Randin D., Vollenweider P., Vollenweider L., Nicod P. Nitric oxide release accounts for insulin's vascular effects in humans. J. Clin. Invest. 1994, 94:2511-2515.
24. Stout R.W., Bierman E.L., Ross R. Effect of insulin on the proliferation of cultured primate arterial smooth muscle cells. Circ. Res. 1975, 36:319-327.
25. Begum N., Song Y., Rienzie J., Ragolia L. Vascular smooth muscle cell growth and insulin regulation of mitogen-activated protein kinase in hypertension. Am. J. Physiol. 1998, 275:C42-C49.
26. Hsueh W.A., Law R.E. Insulin signaling in the arterial wall. Am. J. Cardiol. 1999, 84:21J-24J.
27. Taniyama Y., Ushio-Fukai M., Hitomi H., Rocic P., Kingsley M.J., Pfahnl C., Weber D.S., Alexander R.W., Griendling K.K. Role of p38 MAPK and MAPKAPK-2 in angiotensin II-induced Akt activation in vascular smooth muscle cells. Am. J. Physiol. Cell Physiol. 2004, 287:C494-C499.
28. Kim B., Cheng H.L., Margolis B., Feldman E.L. Insulin receptor substrate 2 and Shc play different roles in insulin-like growth factor I signaling. J. Biol. Chem. 1998, 273:34543-34550.
29. Cantley L.C. The phosphoinositide 3-kinase pathway. Science 2002, 296:1655-1657.
30. Radhakrishnan Y., Maile L.A., Ling Y., Graves L.M., Clemmons D.R. Insulin-like growth factor-I stimulates Shc-dependent phosphatidylinositol 3-kinase activation via Grb2-associated p85 in vascular smooth muscle cells. J. Biol. Chem. 2008, 283:16320-16331.
31. Arnqvist H.J., Bornfeldt K.E., Chen Y., Lindstrom T. The insulin-like growth factor system in vascular smooth muscle: interaction with insulin and growth factors. Metabolism 1995, 44:58-66.
32. Bornfeldt K.E., Gidlof R.A., Wasteson A., Lake M., Skottner A., Arnqvist H.J. Binding and biological effects of insulin, insulin analogues and insulin-like growth factors in rat aortic smooth muscle cells. Comparison of maximal growth promoting activities. Diabetologia 1991, 34:307-313.
33. Ruiz-Torres A., Lozano R., Melon J., Carraro R. On how insulin may influence ageing and become atherogenic throughout the insulin-like growth factor-1 receptor pathway: in vitro studies with human vascular smooth muscle cells. Gerontology 2005, 51:225-230.
34. Engberding N., San Martin A., Martin-Garrido A., Koga M., Pounkova L., Lyons E., Lassegue B., Griendling K.K. Insulin-like growth factor-1 receptor expression masks the antiinflammatory and glucose uptake capacity of insulin in vascular smooth muscle cells. Arterioscler. Thromb. Vasc. Biol. 2009, 29:408-415.
35. Standley P.R., Stanley M.A., Senechal P. Activation of mitogenic and antimitogenic pathways in cyclically stretched arterial smooth muscle. Am. J. Physiol. Endocrinol. Metab. 2001, 281:E1165-E1171.
36. Du J., Meng X.P., Delafontaine P. Transcriptional regulation of the insulin-like growth factor-I receptor gene: evidence for protein kinase C-dependent and -independent pathways. Endocrinology 1996, 137:1378-1384.
37. Du J., Peng T., Scheidegger K.J., Delafontaine P. Angiotensin II activation of insulin-like growth factor 1 receptor transcription is mediated by a tyrosine kinase-dependent redox-sensitive mechanism. Arterioscler. Thromb. Vasc. Biol. 1999, 19:2119-2126.
38. Du J., Brink M., Peng T., Mottironi B., Delafontaine P. Thrombin regulates insulin-like growth factor-1 receptor transcription in vascular smooth muscle: characterization of the signaling pathway. Circ. Res. 2001, 88:1044-1052.